Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
This study has been completed.
Study NCT00004827   Information provided by FDA Office of Orphan Products Development
First Received: February 24, 2000   Last Updated: May 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinitis Pigmentosa
Additional conditions recognized in this trial
Retinitis
More general conditions related to this trial
Eye Diseases
Eye Diseases, Hereditary
Genetic Diseases, Inborn
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
docosahexaenoic acid
Sponsors listed in this trial
FDA Office of Orphan Products Development
Retina Foundation of the Southwest


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services